| abstract |
The present invention provides a pharmaceutical composition comprising one or more ISCOM complexes and one or more ectodomains obtained from one or more hemagglutinin (HA) domains obtained from one or more influenza viruses and one or more neuraminidase (NA) domains , Wherein the Ecto domain corresponds to an Ecto domain isolated from influenza virus. The present invention also relates to a kit. The compositions of the invention may also be used, for example, as an immune stimulating medicine, an immune modulating pharmaceutical, or a vaccine against influenza in vertebrates such as birds and mammals. |